Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Stefanoudaki, E."'
Background/Aim: Primary mediastinal large Bcell lymphoma (PMLBCL) is an aggressive B-cell non- Hodgkin lymphoma (NHL), whose prognosis has greatly improved since the incorporation of the anti-CD20 monoclonal antibody rituximab into current therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::aac0fd8434bc5524bf5c24e52f2d534c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
Publikováno v:
In Agriculture, Ecosystems and Environment 2010 138(3):293-298
Publikováno v:
Advances in Horticultural Science, 1999 Jan 01. 13(1), 6-11.
Externí odkaz:
https://www.jstor.org/stable/42881974
Solitary plasmacytoma (SP) is a rare plasma cell dyscrasia characterized by the presence of bone or extramedullary plasma cell tumors. The treatment of choice is local radiotherapy (R/T)±surgical excision. The role of adjuvant chemotherapy (C/T) or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::24fcb027eb84821da1409db1058c2337
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127175
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127175
Autor:
Fokaides, P., Christoforou, E., Kylili, A., Polycarpou, P., Christodoulou, N., Stefanoudaki, E., Barbopoulou, E., Antoniou, C., Katzourakis, M.
Olive husk is an unexploited source of biomass that can potentially satisfy a significant part of the energy market in Greece and Cyprus. Within the context of this study, mechanisms for estimating the potential contribution of olive husk to the ener
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee63df4a5b4370d53e914102c5998b98
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background: Multiple myeloma (MM) affects mainly elderly persons and because the population of octogenarians increases, it is common to treat patients ≥80 years of age. These patients are often not included in clinical trials; thus, there is limite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::0938b431220d9d67e022f153ffd79a77
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3128654
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3128654
The recently proposed, ISSWM staging system for symptomatic patients with WM was based on patients treated with alkylating agents and nucleoside analogs and has not been externally validated nor has been validated for cause-specific survival (CSS). W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a6c0d0454d1e7a3247011893b8e3027f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089517
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089517